5 results
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Ventilator-Associated Pneumonia ... Coverage and Double Antipseudomonal ... InfectiousDiseases #Empiric #Antibiotics ... #VAP #VentilatorAssociatedPneumonia ... #IDSA2016
Table 4. Recommended Initial Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (Non-Ventilator-Associated Pneumonia) #Management #InfectiousDiseases #Empiric #Antibiotics
Initial Empiric Antibiotic ... Hospital-Acquired Pneumonia ... Non-Ventilator-Associated Pneumonia ... #HAP #HCAP #HospitalAcquiredPneumonia ... #IDSA2016
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Community-Acquired Pneumonia ... (CAP) No comorbidities ... Community #Acquired #Pneumonia ... #Antibiotics #Treatment ... Management #Guidelines #pharmacology
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Anti-Pseudomonal - Antibiotics ... Polymyxin B(IV) #Pharmacology ... #Antibiotics #Review ... #Overview #AntiPseudomonal ... #AntiPseudomonas
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
Azithromycin - Antibiotics ... community-acquired pneumonia ... Ceftriaxone for CAP ... #Pharmacology #Antibiotics